Etiology of tricuspid regurgitation and mortality: a multicenter cohort study
In a large cohort of patients with significant TR, and after adjusting for clinical and echocardiographic variables, all etiological groups exhibited a higher mortality risk compared to atrial TR. Additionally, male patients with TR had a higher mortality risk, while beta-blocker therapy emerged as a protective factor.
Authors
- Manuel García del Río
- Miguel Romero‐Cuevas (ORCID: https://orcid.org/0000-0002-8323-0893)
- Paloma Márquez-Camas
- Mora Murri (ORCID: https://orcid.org/0000-0002-6482-192X)
- D F Arroyo Monino
- Mario Gutiérrez‐Bedmar (ORCID: https://orcid.org/0000-0003-0898-8212)
- David Couto‐Mallón (ORCID: https://orcid.org/0000-0002-1112-4063)
- Marinela Chaparro‐Muñoz
- J Carmona-Carmona
- Francisco Javier Pavón (ORCID: https://orcid.org/0000-0002-5256-8904)
- Manuel F. Jiménez‐Navarro (ORCID: https://orcid.org/0000-0002-6759-0514)
- Jorge Rodríguez‐Capitán (ORCID: https://orcid.org/0000-0001-6650-6264)
- Jorge Segovia-Reyes
- José Raúl López Salguero
- Matías Soler-González
- Teodora Egido de la Iglesia
Institutions
- Universidad de Salamanca (ES)
- Instituto de Salud Carlos III (ES)
- Hospital Universitario Virgen Macarena (ES)
- Centro de Investigación en Red en Enfermedades Cardiovasculares (ES)
- Centro de Investigación Biomédica en Red (ES)
- Complexo Hospitalario Universitario A Coruña (ES)
- Andalusian Centre for Nanomedicine and Biotechnology (ES)
- Barraquer Opthalmology Center (ES)
- Sociedad Española de Cardiología (ES)
- Hospital Clínico Universitario Virgen de la Victoria (ES)
- Instituto de Investigación Biomédica de A Coruña (ES)
- Instituto de Investigación Biomédica de Málaga (ES)
- Universidad de Málaga (ES)
Publication Details
- Journal
- Clinical Research in Cardiology
- Published
- 2025-05-08
- DOI
- https://doi.org/10.1007/s00392-025-02662-z
- Citations
- 2
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.78
Funders
- Universidad de Málaga
- European Commission
- Instituto de Salud Carlos III